KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Resmed (RMD) FCF Payout Ratio (2016 - 2025)

Historic FCF Payout Ratio for Resmed (RMD) over the last 14 years, with Q4 2025 value amounting to 0.28.

  • Resmed's FCF Payout Ratio rose 431.45% to 0.28 in Q4 2025 from the same period last year, while for Dec 2025 it was 0.18, marking a year-over-year decrease of 1341.53%. This contributed to the annual value of 0.19 for FY2025, which is 1373.46% down from last year.
  • Per Resmed's latest filing, its FCF Payout Ratio stood at 0.28 for Q4 2025, which was up 431.45% from 0.21 recorded in Q3 2025.
  • In the past 5 years, Resmed's FCF Payout Ratio ranged from a high of 4.13 in Q3 2022 and a low of 0.66 during Q3 2021
  • For the 5-year period, Resmed's FCF Payout Ratio averaged around 0.5, with its median value being 0.28 (2023).
  • Its FCF Payout Ratio has fluctuated over the past 5 years, first plummeted by 25194.11% in 2021, then surged by 72747.85% in 2022.
  • Resmed's FCF Payout Ratio (Quarter) stood at 0.32 in 2021, then soared by 97.01% to 0.64 in 2022, then plummeted by 55.51% to 0.28 in 2023, then dropped by 4.77% to 0.27 in 2024, then grew by 4.31% to 0.28 in 2025.
  • Its last three reported values are 0.28 in Q4 2025, 0.21 for Q3 2025, and 0.15 during Q2 2025.